Browse EX-10 agreements

EMPLOYMENT AGREEMENT

THIS EMPLOYMENT AGREEMENT (“Agreement”) is entered into as of the date fully executed by and between Michael Wanderer (“Executive”) and Angi Inc., a Delaware corporation (the “Company”), and is effective as of May 4, 2026 (the “Effective Date”).

WHEREAS, the Company desires to establish its right to the services of Executive, in the capacity described below, on the terms and conditions hereinafter set forth, and Executive is willing to accept such employment on such terms and conditions.

NOW, THEREFORE, in consideration of the mutual agreements hereinafter set forth, Executive and the Company have agreed and do hereby agree as follows:

…

1 PERFORMANCE-VESTED RESTRICTED STOCK UNIT WITH RELATIVE TOTAL SHAREHOLDER RETURN MODIFIER AGREEMENT This PERFORMANCE-VESTED RESTRICTED STOCK UNIT WITH RELATIVE TOTAL SHAREHOLDER RETURN MODIFIER AGREEMENT (this “Agreement”), dated as of /$GrantDate$/ (the “Grant Date”), is between ZEBRA TECHNOLOGIES CORPORATION, a Delaware corporation (the “Company”), and /$ParticipantName$/ (the “Participant”). This Agreement evidences an Award being granted to the Participant under the Zebra Technologies Corporation 2026 Long-Term Incentive Plan (the “Plan”) in the form of performance-vested restricted stock units (“RSUs”). Capitalized terms used in this Agreement without definitions shall have the meanings ascribed to such terms in the Plan. 1. Grant of RSUs. (a) Grant. Subject to the provisions of this Agreement and pursuant to the provisions of the Plan, the Company hereby grants to the Participant as of the Grant Date /$GrantTxt$/ restricted stock units (the “Target Number of RSUs”). Zero percent (0%) to two hundred percent (200%) of the Target Number of RSUs may be earned based on the Company’

…

1 TIME-VESTED RESTRICTED STOCK UNIT AGREEMENT This TIME-VESTED RESTRICTED STOCK UNIT AGREEMENT (this “Agreement”), dated as of /$GrantDate$/ (the “Grant Date”), is between ZEBRA TECHNOLOGIES CORPORATION, a Delaware corporation (the “Company”), and /$ParticipantName$/ (the “Participant”). This Agreement evidences an Award being granted to the Participant under the Zebra Technologies Corporation 2026 Long-Term Incentive Plan (the “Plan”) in the form of time-vested restricted stock units (“RSUs”). Capitalized terms used in this Agreement without definitions shall have the meanings ascribed to such terms in the Plan. 1. Grant. (a) Grant. Subject to the provisions of this Agreement and pursuant to the provisions of the Plan, the Company hereby grants to the Participant as of the Grant Date /$GrantTxt$/ RSUs, each of which represents the right to receive, subject to the vesting provisions below, one Share. This Agreement shall be null and void unless the Participant accepts this Agreement through the Company’s electronic delivery and acceptance process operated by Merrill not later than /$

…

1 PERFORMANCE-VESTED RESTRICTED STOCK UNIT AGREEMENT This PERFORMANCE-VESTED RESTRICTED STOCK UNIT AGREEMENT (this “Agreement”), dated as of /$GrantDate$/ (the “Grant Date”), is between ZEBRA TECHNOLOGIES CORPORATION, a Delaware corporation (the “Company”), and /$ParticipantName$/ (the “Participant”). This Agreement evidences an Award being granted to the Participant under the Zebra Technologies Corporation 2026 Long-Term Incentive Plan (the “Plan”) in the form of performance-vested restricted stock units (“RSUs”). Capitalized terms used in this Agreement without definitions shall have the meanings ascribed to such terms in the Plan. 1. Grant of RSUs. (a) Grant. Subject to the provisions of this Agreement and pursuant to the provisions of the Plan, the Company hereby grants to the Participant as of the Grant Date /$GrantTxt$/ restricted stock units (the “Target Number of RSUs”). Zero percent (0%) to two hundred percent (200%) of the Target Number of RSUs may be earned based on the Company’s results in accordance with Exhibit A. This Agreement shall be null and void unless the Partici

…

CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [*], HAS BEEN OMITTED BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL.

Exhibit 10.5

AMENDMENT NO. 1 TO AMENDED AND RESTATED CREDIT, SECURITY AND GUARANTY AGREEMENT

This AMENDMENT NO. 1 TO AMENDED AND RESTATED CREDIT, SECURITY AND GUARANTEE AGREEMENT (this“Agreement”)ismadeasofthis11thdayofMay,2026,byandamong RIGEL PHARMACEUTICALS, INC., a Delaware corporation (“Rigel”), as a Borrower, MIDCAP FUNDINGIVTRUST,asAgent(insuchcapacity,togetherwithitssuccessorsandassigns,“Agent”)and the financial institutions or other entities from time to time parties to the Credit Agreement referenced below, each as a Lender.

RECITALS

…

CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [*], HAS BEEN OMITTED BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL.

Exhibit 10.6

LICENSE AGREEMENT

by and among

ARVINAS, INC.,

ARVINAS OPERATIONS, INC.,

ARVINAS ESTROGEN RECEPTOR, INC.,

PFIZER INC.,

and

RIGEL PHARMACEUTICALS, INC.

---

CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [*], HAS BEEN OMITTED BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL.

TABLE OF CONTENTS

Page

Section 2.    License Grants    22

Section 3.    Transfer of Licensed Know-How.    26

Section 4.    Development.    26

Section 5.    Regulatory Submissions and Regulatory Approvals.    29

Section 6.    Commercialization.    30

…

Rigel Pharmaceuticals, Inc.

Inducement Plan

Adopted by the Compensation Committee: October 10, 2016

Amended by the Compensation Committee: January 3, 2017

Amended by the Compensation Committee: August 16, 2017

Amended by the Compensation Committee: November 7, 2017

Amended by the Compensation Committee: December 23, 2017

Amended by the Compensation Committee: January 24, 2018

Amended by the Compensation Committee: August 19, 2020

Amended by the Compensation Committee: September 30, 2021

Amended by the Compensation Committee: January 4, 2022

Amended by the Compensation Committee: April 4, 2022

Amended by the Compensation Committee: December 8, 2022

Amended by the Compensation Committee: April 4, 2023

Amended by the Compensation Committee: June 29, 2023

Amended by the Compensation Committee: October 3, 2023

Amended by the Compensation Committee: December 26, 2023

Amended by the Compensation Committee: March 26, 2024

Amended by the Compensation Committee: April 5, 2024

Amended by the Compensation Committee: July 8, 2024

…

CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [*], HAS BEEN OMITTED BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL.

Exhibit 10.4

AMENDEDANDRESTATED

CREDIT,SECURITYANDGUARANTYAGREEMENT

datedasofMay5,2026 by and among

RIGELPHARMACEUTICALS,INC.,

asBorrowerandanyadditionalborrowerthathereafterbecomespartyhereto,eachasBorrower, and collectively as Borrowers,

and

anyguarantorthathereafterbecomespartyhereto,eachasGuarantor,andcollectivelyas Guarantors,

and

MIDCAPFUNDINGIVTRUST,

asAgent, and

THELENDERS

FROMTIMETOTIMEPARTYHERETO

i

---

CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [*], HAS BEEN OMITTED BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL.

TABLEOFCONTENTS

Page

ARTICLE1-DEFINITIONS.    1

Section1.1    CertainDefinedTerms    1

Section1.2    AccountingTermsandDeterminations    43

Section1.3    OtherDefinitionalandInterpretiveProvisions    44

…

Rigel Pharmaceuticals, Inc.

2018 Equity Incentive Plan

Adopted by the Board of Directors: February 1, 2018

Approved by the Stockholders: May 16, 2018

Amended January 23,2019

Amended January 31, 2019

Approved by the Stockholders: May 22, 2019

Amended February 3, 2020

Approved by the Stockholders: May 14, 2020

Amended January 28, 2021

Amended March 9, 2021

Approved by the Stockholders: May 18, 2021

Approved by the Stockholders: May 19, 2022

Approved by the Stockholders: May 25, 2023

Approved by the Stockholders: May 24, 2024

Approved by the Stockholders: May 22, 2025

Approved by the Stockholders: May 14, 2026

1.    General.

…

RIGEL PHARMACEUTICALS, INC.

2000 EMPLOYEE STOCK PURCHASE PLAN

Approved by the Board of Directors August 18, 2000

Approved by Stockholders September 11, 2000

Amended and Restated April 24, 2003

Approved By Stockholders June 20, 2003

Amended January 31, 2007

Approved by Stockholders May 31, 2007

Amended by the Compensation Committee November 13, 2008

Amended by the Compensation Committee January 20, 2010
Amended by the Board of Directors February 4, 2014
Approved by the Stockholders May 20, 2014

Amended by the Compensation Committee December 9, 2020

Amended by the Board of Directors January 25, 2021
Approved by the Stockholders May 18, 2021

Approved by the Stockholders May 11, 2026

1.Purpose.

(a)The purpose of this 2000 Employee Stock Purchase Plan (the “Plan”) is to provide a means by which employees of Rigel Pharmaceuticals, Inc. (the “Company”) and its Affiliates, as defined in subparagraph 1(b), that are designated as provided in subparagraph 2(b), may be given an opportunity to purchase common stock of the Company (the “Common Stock”).

…

AMENDMENT TO EMPLOYMENT AGREEMENT

THIS AMENDMENT TO EMPLOYMENT AGREEMENT (this “Amendment”) is effective as of July 1, 2026, (the “Effective Date”) by and between Xometry, Inc. (the “Company”), and Sanjeev Singh Sahni (“Executive”) (collectively referred to as the “Parties” or individually referred to as a “Party”).

WHEREAS, the Company and Executive previously entered into that certain Employment Agreement, effective as of November 5, 2024 (the “Employment Agreement”);

WHEREAS, the Company desires for the Executive to serve as the Company Chief Executive Officer and on the Company Board of Directors, pursuant to the terms of this Amendment; and

WHEREAS, the Parties wish to amend the Employment Agreement as set forth herein.

NOW, THEREFORE, in consideration of the premises and mutual covenants herein and for other good and valuable consideration, the Parties agree as follows:

1.

Amendments to Employment Agreement.

a)

…

SECOND AMENDMENT TO EMPLOYMENT AGREEMENT

THIS SECOND AMENDMENT TO THE AMENDED AND RESTATED EMPLOYMENT AGREEMENT (this “Second Amendment”) is entered into as of July 1, 2026, (the “Effective Date”) by and between Xometry, Inc. (the “Company”), and Randolph Altschuler (“Executive”) (collectively referred to as the “Parties” or individually referred to as a “Party”).

WHEREAS, the Company and Executive previously entered into that certain Amended and Restated Employment Agreement, effective as of July 2, 2021 (the “Employment Agreement”), and the Amendment to the Employment Agreement, effective as of June 14, 2024 (the “Amendment”);

WHEREAS, the Company desires for the Executive to serve as the Executive Chair of the Company Board of Directors, pursuant to the terms of this Second Amendment, and

WHEREAS, the Parties wish to amend the Employment Agreement as set forth herein.

NOW, THEREFORE, in consideration of the premises and mutual covenants herein and for other good and valuable consideration, the Parties agree as follows:

1.

Amendments to Employment Agreement.

…